GAD-Alum (Diamyd) Administered Into Lymph Nodes in Combination With Vitamin D in Type 1 Diabetes (DIAGNODE-1)

Clinical trial NCT02352974 · COMPLETED

Trial details

NCT number: NCT02352974
Sponsor: Johnny Ludvigsson
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 1

Start date: 2015-01-01
Primary completion: 2019-10-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.